Page last updated: 2024-09-04

torcetrapib and Myocardial Infarction

torcetrapib has been researched along with Myocardial Infarction in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DeLisle, RK; Ganz, P; Hyde, C; Malarstig, A; Murthy, AC; Ostroff, R; Segal, MR; Weiss, SJ; Williams, SA	1
Francis, DP; Keene, D; Price, C; Shun-Shin, MJ	1
Schaefer, JR	1
SoRelle, R	1

Reviews

2 review(s) available for torcetrapib and Myocardial Infarction

Article	Year
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ (Clinical research ed.), 2014, Jul-18, Volume: 349 Topics: Amides; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Coronary Disease; Esters; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Myocardial Infarction; Niacin; Oxazolidinones; Quinolines; Randomized Controlled Trials as Topic; Stroke; Sulfhydryl Compounds	2014
[HDL level or HDL function as the primary target in preventive cardiology]. Herz, 2012, Volume: 37, Issue:1 Topics: Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fluorobenzenes; Heptanoic Acids; Humans; Male; Membrane Transport Proteins; Myocardial Infarction; Niacin; Pyrimidines; Pyrroles; Quinolines; Randomized Controlled Trials as Topic; Reference Values; Rosuvastatin Calcium; Scavenger Receptors, Class B; Sulfonamides; Survival Rate; Up-Regulation	2012

Article

Year

Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.

BMJ (Clinical research ed.), 2014, Jul-18, Volume: 349

Topics: Amides; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Coronary Disease; Esters; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Myocardial Infarction; Niacin; Oxazolidinones; Quinolines; Randomized Controlled Trials as Topic; Stroke; Sulfhydryl Compounds

2014

[HDL level or HDL function as the primary target in preventive cardiology].

Herz, 2012, Volume: 37, Issue:1

Topics: Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fluorobenzenes; Heptanoic Acids; Humans; Male; Membrane Transport Proteins; Myocardial Infarction; Niacin; Pyrimidines; Pyrroles; Quinolines; Randomized Controlled Trials as Topic; Reference Values; Rosuvastatin Calcium; Scavenger Receptors, Class B; Sulfonamides; Survival Rate; Up-Regulation

2012

Trials

1 trial(s) available for torcetrapib and Myocardial Infarction

Article	Year
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib. Circulation, 2018, 03-06, Volume: 137, Issue:10 Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Cholesterol Ester Transfer Proteins; Drug-Related Side Effects and Adverse Reactions; Early Diagnosis; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Proteomics; Quinolines; Stroke; Survival Analysis	2018

Article

Year

Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.

Circulation, 2018, 03-06, Volume: 137, Issue:10

Topics: Aged; Aldosterone; Anticholesteremic Agents; Biomarkers, Pharmacological; Case-Control Studies; Cholesterol Ester Transfer Proteins; Drug-Related Side Effects and Adverse Reactions; Early Diagnosis; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Proteomics; Quinolines; Stroke; Survival Analysis

2018

Other Studies

1 other study(ies) available for torcetrapib and Myocardial Infarction

Article	Year
Procalcitonin and infective endocarditis. Circulation, 2004, Apr-13, Volume: 109, Issue:14 Topics: Abciximab; Antibodies, Monoclonal; Biomarkers; Calcitonin; Calcitonin Gene-Related Peptide; Cardiology; Cholesterol, HDL; Combined Modality Therapy; Endocarditis, Bacterial; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Protein Precursors; Quinolines; Stents	2004